|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-6-15
|
|
pubmed:abstractText |
To evaluate whether treatment with single-agent docetaxel would result in longer survival than would best supportive care in patients with non-small-cell lung cancer who had previously been treated with platinum-based chemotherapy. Secondary end points included assessment of response (docetaxel arm only), toxicity, and quality of life.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BerilleJJ,
pubmed-author:BurkesRR,
pubmed-author:CoughlinSS,
pubmed-author:DanceyJJ,
pubmed-author:GrallaRR,
pubmed-author:GressotLL,
pubmed-author:KimYY,
pubmed-author:LevitasAA,
pubmed-author:MattsonKK,
pubmed-author:O'RourkeMM,
pubmed-author:RamlauRR,
pubmed-author:ShepherdF AFA,
pubmed-author:VincentMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2095-103
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10811675-Adult,
pubmed-meshheading:10811675-Aged,
pubmed-meshheading:10811675-Antineoplastic Agents,
pubmed-meshheading:10811675-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10811675-Carboplatin,
pubmed-meshheading:10811675-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10811675-Chi-Square Distribution,
pubmed-meshheading:10811675-Cisplatin,
pubmed-meshheading:10811675-Disease Progression,
pubmed-meshheading:10811675-Female,
pubmed-meshheading:10811675-Humans,
pubmed-meshheading:10811675-Lung Neoplasms,
pubmed-meshheading:10811675-Male,
pubmed-meshheading:10811675-Middle Aged,
pubmed-meshheading:10811675-Paclitaxel,
pubmed-meshheading:10811675-Palliative Care,
pubmed-meshheading:10811675-Proportional Hazards Models,
pubmed-meshheading:10811675-Prospective Studies,
pubmed-meshheading:10811675-Quality of Life,
pubmed-meshheading:10811675-Survival Analysis,
pubmed-meshheading:10811675-Taxoids,
pubmed-meshheading:10811675-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
|
|
pubmed:affiliation |
University of Toronto, Toronto, and London Regional Cancer Centre, London, Ontario, Canada. fshepherd@torhosp.toronto.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
